AHMAD ELZOKAKY: Open Payments
NPI 1073181962 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 16 payments from 8 companies in 2025. Trend: 2023 $1,381 · 2024 $1,044 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $257 |
| ABBVIE INC. | 3 | $180 |
| Janssen Pharmaceuticals, Inc | 3 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $166 |
| Axsome Therapeutics, Inc. | 1 | $143 |
| Corium, LLC | 1 | $26 |
| Tris Pharma Inc | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: UZEDY, VRAYLAR, SPRAVATO, CAPLYTA, Auvelity, Azstarys, Dyanavel XR, Jornay PM.
Industry payments across IL — which companies pay providers there.
